Jan 292016
 January 29, 2016
Marijuana And Cannabinoids: A Neuroscience Research Summit

This is a notice of a conference of significance in the medical cannabis field. The Research Summit will be held on March 22-23 at the Natcher Conference Center on the National Institutes of Health campus in Bethesda, Maryland. After viewing the advertisement for the event I question the premise, as the cannabinoid system itself has no adverse effects; the phrasing of the event’s summary implies a bias toward finding harm, a charge that Dr. Sanjay Gupta and other have levied against the NIH and NIDA for some time. The discussions will include a Michigan contingent, as Dr. Christine Rabinak from Wayne

Read More
Jan 262016
 January 26, 2016
Study: Vaporizers Deliver Safe And Reliable Doses Of Cannabinoids

By Paul Armentano, NORML Deputy Director Electronically driven vaporizers deliver cannabinoids in a relatively safe and reliable manner, according to data published in the journal PLOS ONE. Swiss investigators evaluated the ability of various types of vaporizer technologies to safely and effectively release THC and CBD (cannabidiol) in vapor. Researchers reported that electronically driven devices, which allow for precise temperature control, were able to provide for relatively safe and uniform dosing. By contrast, gas-powered devices performed in a more unreliable manner and “cannot be recommended for therapeutic purposes.” Authors concluded, “[T]he four electrically-driven and temperature-controlled vaporizers investigated in this study

Read More
Jan 202016
 January 20, 2016
Study: Marijuana Extract Oil Mitigates Symptoms Of Alzheimer's-Induced Dementia

By Paul Armentano, NORML Deputy Director The administration of liquid cannabis extracts containing THC is associated with the mitigation of various symptoms of Alzheimer’s-related agitation and dementia, according to observational trial data published online ahead of print in The Journal of Alzheimer’s Disease. Israeli investigators assessed the use of cannabis oil as an adjunct pharmacotherapy treatment in ten Alzheimer’s disease patients over a period of several weeks. Researchers reported that drug administration was associated with a significant reduction in patients’ symptom severity scores. Specifically, cannabis oil ingestion corresponded with decreased levels of aggression, irritability, apathy, and delusions. Investigators concluded, “Adding medical

Read More
Jan 182016
 January 18, 2016
Learn The Truth About CBD At The Virtual Cannabis Health Summit

Cannabidiol (CBD) has been in the news a lot lately, and for good reason. CBD has proven to be very effective in helping treat a lot of different conditions. The one that is in the news a lot is epilepsy, but CBD is good for a lot of things. Because of increased media coverage, the interest in CBD has grown significantly in recent years. But with that increased interest there has also been an increase in misleading information about CBD, and a huge industry built around junky CBD products that are made with very bad ingredients from overseas. I get

Read More
Jan 182016
 January 18, 2016
First Of Its Kind Study Concludes That Using Marijuana As A Teen Does Not Lower IQ

Marijuana opponents often say that consuming marijuana makes a person dumber. Many opponents specifically point towards marijuana use as a teenager and try to link it to a lower IQ later in life. Those claims almost always point to a long debunked study that concluded that marijuana use as a teenager would lower a person’s IQ 8 points later in life. The results of another study were recently released which concluded that using marijuana as a teenager does not lower one’s IQ. Per Oregon Live: If smoking pot harmed test scores, the researchers reasoned, people who’d smoked more pot should show

Read More
Jan 132016
 January 13, 2016
Who Will Be Speaking At The Free Virtual Cannabis Health Summit On January 23-24?

The topic of medical marijuana is very complex. It’s more than just buying a bag of cannabis from someone, rolling it into joints, and smoking it. Chances are if you are reading this blog post, it’s because you suffer from some type of ailment or condition, and want to know more about how medical cannabis can help your situation. I know a lot of people that are in that boat, and get e-mails from people everyday asking for advice on how to treat their ailment or condition. I always tell them that while I have researched the topic a lot,

Read More
Jan 132016
 January 13, 2016
Study: Marijuana Use Associated With Decreased Migraine Frequency

By Paul Armentano, NORML Deputy Director Cannabis administration is associated with decreased migraine headache frequency, according to data published online ahead of print in the journal Pharmacotherapy. Investigators at the University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences retrospectively assessed cannabis’ effects on monthly migraine headache frequency in a group of 121 adults. Study participants had a primary diagnosis of migraine headache, had been recommended cannabis by a physicians for migraine treatment, and had participated in at least one follow up medical visit. Authors reported that 85 percent of subjects reported a decrease in migraine frequency and 12

Read More
Jan 102016
 January 10, 2016
Which Is Worse For You - Marijuana Smoke Or Tobacco Smoke?

There are a lot of people out there that think that marijuana smoke and tobacco smoke are the same, and that both are equally bad for you. But is that true? What does science have to say about the matter? More and more states are legalizing medical marijuana, but banning smoke-able forms of cannabis due to fears that marijuana smoke is the same as tobacco smoke. Minnesota and New York are examples of that. One of my heroes, Paul Armentano of NORML, recently wrote about this topic. Below are some excerpts from his article: Writing in the Harm Reduction Journal in

Read More
Dec 232015
 December 23, 2015
DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

The United States Drug Enforcement Administration (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances Act (CSA) for those who are conducting FDA-approved clinical trials on cannabidiol (CBD), an extract of the marijuana plant.  These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.  The DEA notified affected researchers by letter of the changes, which take effect immediately. Federal Regulation (21 CFR 1301.18) requires researchers conducting CBD-based clinical trials under an FDA Investigational New Drug Application to have a DEA research registration.  This registration permits the possession of

Read More
Dec 142015
 December 14, 2015
University Of Vermont Offering A Course On Medical Marijuana Science

I attended college from the age of 24-28. I was a ‘non-traditional student’ as the faculty always reminded me, which always seemed like a passive aggressive form of age discrimination. It was bad enough that I couldn’t relate to most of my classmates because they had barely moved out of their parents house and didn’t have the life experience that I had accumulated up to that point. But college was still a very fun time. In every class I was in, I would always try to steer the class conversations towards marijuana in anyway that I could. I graduated in

Read More